EPIDERMOLYSIS BULLOSA ACQUISITA

Course overview

EPIDERMOLYSIS BULLOSA ACQUISITA (EBA) IS A RARE, CHRONIC AUTOIMMUNE BLISTERING DISEASE THAT AFFECTS BOTH THE SKIN AND MUCOUS MEMBRANES. THIS CONDITION ARISES DUE TO AUTOANTIBODIES TARGETING TYPE VII COLLAGEN—A CRUCIAL COMPONENT OF ANCHORING FIBRILS WITHIN THE DERMAL-EPIDERMAL JUNCTION. ALTHOUGH EBA CAN MANIFEST IN VARIOUS PHENOTYPES CLINICALLY, THE CLASSICAL MECHANOBULLOUS AND INFLAMMATORY FORMS ARE THE MOST COMMON PRESENTATIONS. THIS ACTIVITY OFFERS INSIGHTS INTO THE UNDERLYING PATHOGENESIS OF EBA, INVOLVING THE PRODUCTION OF AUTOANTIBODIES TARGETING TYPE VII COLLAGEN, WHICH LEAD TO EPIDERMAL DETACHMENT AND THE DISTINCTIVE CLINICAL FEATURES OBSERVED IN EBA. THIS ACTIVITY COMPREHENSIVELY REVIEWS THE EPIDEMIOLOGY, DIAGNOSTIC APPROACHES, DIFFERENTIAL DIAGNOSIS, CURRENT TREATMENT OPTIONS, AND CHALLENGES CLINICIANS FACE IN MANAGING EBA. THIS COURSE ASSISTS INTERPROFESSIONAL HEALTHCARE TEAM MEMBERS ENHANCE THEIR COMPETENCE TO MAKE WELL-INFORMED DECISIONS WHEN CARING FOR PATIENTS WITH EBA.